601607 On Other Exchanges
601607 is not on other exchanges.

shanghai pharmaceuticals-a (601607) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SHANGHAI PHARMACEUTICALS-A (601607)

Related News

No related news articles were found.

shanghai pharmaceuticals-a (601607) Related Businessweek News

No Related Businessweek News Found

shanghai pharmaceuticals-a (601607) Details

Shanghai Pharmaceuticals Holding Co., Ltd., together with its subsidiaries, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People’s Republic of China. It operates through Production, Distribution, Retail, and Others segments. It offers a range of products, including chemical and bio-pharms, modern Chinese medicine, healthcare products, medical devices, etc. in various therapeutic areas, such as cardiovascular, systemic anti-infections, digestive system and immune-metabolism, neuropsychiatric, and antineoplastic, as well as anti-tumor and immunomodulatory, musculo-skeletal, respiratory, genito-urinary and sex hormone, blood and blood-forming organ, neurological, alimentary tract, and other therapeutic areas. The company provides its products in various dosage forms that include tablets, capsules, powder, mini-volume injections, eye-drops, inhalants, coagulants, etc. It also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company operates a network of retail pharmacy stores, as well as engages in consulting service, assets management, investment holding operations, etc. Further, it manufactures and trades medicines and medical equipment; and rents properties, as well as wholesales chemicals and active pharmaceutical ingredients. The company operates 1,800 chained pharmacies in 16 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.

40,852 Employees
Last Reported Date: 03/22/17
Founded in 1994

shanghai pharmaceuticals-a (601607) Top Compensated Officers

President and Executive Director
Total Annual Compensation: CNY2.0M
Compensation as of Fiscal Year 2015.
shanghai pharmaceuticals-a
Shanghai Pharmaceuticals Holding Co., Ltd. Proposes Dividend for the Year Ended December 31, 2016

Shanghai Pharmaceuticals Holding Co., Ltd. announced dividend for the year ended December 31, 2016 of RMB 0.36 per share, amounting to total dividend of RMB 968,008,000, and is subject to the shareholders' approval at the annual general meeting.

Shanghai Pharmaceuticals Holding Co., Ltd. Reports Consolidated Earnings Results for the Year 2016

Shanghai Pharmaceuticals Holding Co., Ltd. reported consolidated earnings results for the year ended December 31, 2016. For the year, the company reported total revenue of RMB 120,764,660,000 against RMB 105,516,587,000 a year ago. Operating profit was RMB 3,784,556,000 against RMB 3,631,160,000 a year ago. Profit before income tax was RMB 4,638,996,000 against RMB 4,171,854,000 a year ago. Profit attributable to owners of the company was RMB 3,196,394,000 against RMB 2,876,989,000 a year ago. Basic and diluted earnings per share were RMB 1.19 against RMB 1.07 a year ago. Net cash generated from operating activities was RMB 1,218,481,000 against RMB 610,890,000 a year ago. Purchases of property, plant and equipment and investment properties were RMB 1,874,941,000 against RMB 1,581,919,000 a year ago. Purchases of land use rights and intangible assets were RMB 244,344,000 against RMB 138,544,000 a year ago.

Shanghai Pharmaceuticals Holding Co., Ltd., Board Meeting, Mar 21, 2017

Shanghai Pharmaceuticals Holding Co., Ltd., Board Meeting, Mar 21, 2017. Agenda: To consider the purpose of, among other matters, approve the annual results of the company and its subsidiaries for the year ended 31 December 2016 and its publication.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

601607 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 601607.
View Industry Companies

Industry Analysis


Industry Average

Valuation 601607 Industry Range
Price/Earnings 20.1x
Price/Sales 0.5x
Price/Book 2.0x
Price/Cash Flow 14.4x
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SHANGHAI PHARMACEUTICALS-A, please visit www.sphchina.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.